Frequency Therapeutics, Inc.·4

Feb 1, 4:55 PM ET

McCubbin Quentin 4

4 · Frequency Therapeutics, Inc. · Filed Feb 1, 2021

Insider Transaction Report

Form 4
Period: 2021-01-29
McCubbin Quentin
Chief Manufacturing Officer
Transactions
  • Award

    Stock Option

    2021-01-29+90,00090,000 total
    Exercise: $38.99Exp: 2031-01-28Common Stock (90,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% on January 19, 2022, and in equal monthly installments on the same day of each month thereafter and will be fully vested and exercisable on January 19, 2025.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT